phlorhizin has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, RF; Coombs, MRP; Fernando, W; Hoskin, DW; Rupasinghe, HPV | 1 |
| Coombs, MRP; Fernando, W; Hoskin, DW; Rupasinghe, HPV | 1 |
| Chung, MH; Hattori, M; Ma, C; Ma, H; Wang, J; Xue, B | 1 |
3 other study(ies) available for phlorhizin and Breast Neoplasms
| Article | Year |
|---|---|
Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docosahexaenoic Acids; Female; Humans; Neoplastic Stem Cells; Paclitaxel; Phlorhizin; Triple Negative Breast Neoplasms | 2023 |
Docosahexaenoic acid-acylated phloridzin, a novel polyphenol fatty acid ester derivative, is cytotoxic to breast cancer cells.
Topics: Acylation; Animals; Apoptosis; Breast Neoplasms; CDC2 Protein Kinase; Cell Proliferation; Cyclin B1; Cyclin-Dependent Kinases; Docosahexaenoic Acids; Female; Humans; MCF-7 Cells; Mice; Phlorhizin; Polyphenols; Xenograft Model Antitumor Assays | 2016 |
Estrogenic and antiestrogenic activities of phloridzin.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; beta-Galactosidase; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Receptor Modulators; Estrogens; Fagaceae; Female; Glucosides; Humans; Malus; Mice; Mice, Inbred Strains; Organ Size; Phlorhizin; Phytoestrogens; Phytotherapy; Plant Extracts; Receptors, Estrogen; Tissue Distribution; Uterus; Yeasts | 2010 |